Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 206.04 CNY | -0.80% |
|
+0.12% | -19.20% |
| Capitalization | 249B 35.06B 30.23B 27.89B 26.61B 49.18B 3,106B 53.91B 332B 128B 1,483B 131B 129B 5,439B | P/E ratio 2025 * |
25.8x | P/E ratio 2026 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise value | 229B 32.24B 27.8B 25.65B 24.48B 45.23B 2,856B 49.58B 305B 118B 1,364B 121B 118B 5,002B | EV / Sales 2025 * |
6.66x | EV / Sales 2026 * | 5.72x |
| Free-Float |
42.59% | Yield 2025 * |
2.56% | Yield 2026 * | 2.95% |
| 1 day | -0.80% | ||
| 1 week | +0.12% | ||
| Current month | -4.19% | ||
| 1 month | -10.78% | ||
| 3 months | -12.41% | ||
| 6 months | -8.97% | ||
| Current year | -19.20% |
| 1 week | 205.8 |  | 210.88 |
| 1 month | 204.55 | | 227.81 |
| Current year | 204.55 | | 267.1 |
| 1 year | 204.55 | | 278.8 |
| 3 years | 204.55 | | 353 |
| 5 years | 204.55 | | 503.51 |
| 10 years | 58.56 | | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 53 | 2020-11-16 |
Yun Zhao
DFI | Director of Finance/CFO | 42 | 2019-11-14 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 62 | 2021-04-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 63 | 1999-01-24 |
Xi Ting Li
CHM | Chairman | 74 | 2001-12-17 |
Ming He Cheng
BRD | Director/Board Member | 64 | 2017-01-04 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 6.79% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.80% | +0.12% | -23.88% | -35.39% | 35.06B | |
| -2.00% | -0.92% | +10.54% | +5.81% | 213B | |
| -0.51% | -2.37% | +3.62% | +107.84% | 194B | |
| -0.35% | +5.00% | -4.36% | -17.18% | 156B | |
| -0.91% | +1.74% | +16.98% | +136.76% | 151B | |
| -1.28% | -4.77% | -16.30% | -19.51% | 53.88B | |
| -1.81% | +1.62% | +25.06% | +12.94% | 49.17B | |
| -1.57% | -1.51% | +13.73% | -1.77% | 40.97B | |
| +0.10% | -2.70% | +4.25% | +8.96% | 35.72B | |
| -3.44% | -3.31% | -13.61% | - | 32.17B | |
| Average | -1.32% | -1.29% | +1.60% | +22.05% | 96.04B | |
| Weighted average by Cap. | -1.34% | -1.02% | +4.81% | +41.68% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 34.42B 4.84B 4.18B 3.85B 3.68B 6.79B 429B 7.45B 45.81B 17.66B 205B 18.16B 17.79B 751B | 39.27B 5.52B 4.76B 4.39B 4.19B 7.75B 489B 8.5B 52.26B 20.15B 234B 20.72B 20.29B 857B |
| Net income | 9.69B 1.36B 1.18B 1.08B 1.03B 1.91B 121B 2.1B 12.89B 4.97B 57.68B 5.11B 5.01B 211B | 11.5B 1.62B 1.39B 1.29B 1.23B 2.27B 143B 2.49B 15.3B 5.9B 68.44B 6.07B 5.94B 251B |
| Net Debt | -20.03B -2.82B -2.43B -2.24B -2.14B -3.95B -250B -4.33B -26.65B -10.28B -119B -10.57B -10.35B -437B | -24.68B -3.47B -2.99B -2.76B -2.64B -4.87B -308B -5.34B -32.85B -12.67B -147B -13.02B -12.76B -539B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-11-17 | 206.04 ¥ | -0.80% | 4,530,936 |
| 25-11-14 | 207.70 ¥ | -0.24% | 5,173,689 |
| 25-11-13 | 208.21 ¥ | +0.00% | 5,708,983 |
| 25-11-12 | 208.20 ¥ | -0.24% | 7,492,587 |
| 25-11-11 | 208.70 ¥ | -0.31% | 6,099,034 |
End-of-day quote Shenzhen S.E., November 16, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition